+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Ganciclovir for cytomegalovirus cmv infection in renal allograft recipients



Ganciclovir for cytomegalovirus cmv infection in renal allograft recipients



Journal of Urology 145(4 SUPPL): 304A




(PDF emailed within 1 workday: $29.90)

Accession: 031536704

Download citation: RISBibTeXText


Related references

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplantation Proceedings 23(1 Pt 2): 1346-1347, 1991

Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. Journal of Urology 148(5): 1388-1392, 1992

Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. American Journal of Transplantation 2(7): 671-673, 2002

Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease. Transplantation Proceedings 30(5): 2083-2085, 1998

A randomized comparison of ganciclovir and acyclovir for prevention of cytomegalovirus infection in lung allograft recipients. Pharmacotherapy 12(6): 508, 1992

Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients. Transplantation 70(8): 1174-1180, 2000

Ganciclovir for cytomegalovirus infection in renal transplant recipients. Lancet 1(8631): 216-217, 1989

The incidence of cytomegalovirus infection and the effects of immunosuppressants on cytomegalovirus infection in renal allograft recipients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 728A, 2000

Impact of ganciclovir prophylaxis on CMV infection in cadaveric renal allograft recipients. Journal of the American Society of Nephrology 5(3): 1032, 1994

Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrology, Dialysis, Transplantation 8(9): 858-862, 1993

Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrology, Dialysis, Transplantation 4(10): 906-910, 1989

Cytomegalovirus infection in renal transplant recipients 2. an investigation of allograft recipients with viruria. Nishinihon Journal of Urology 46(3): 513-517, 1984

Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transplant Infectious Disease 7(2): 71-74, 2005

Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clinical Transplantation 15(5): 297-308, 2001

Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. Transplantation Proceedings 36(10): 3019-3024, 2005